QMED - QMed, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 517
Enterprise Value 3-326.47k
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.00
Price/Book (mrq)0.00
Enterprise Value/Revenue 3-0.08
Enterprise Value/EBITDA 60.05

Trading Information

Stock Price History

Beta (3Y Monthly) 327.07
52-Week Change 3N/A
S&P500 52-Week Change 31.68%
52 Week High 30.0000
52 Week Low 30.0000
50-Day Moving Average 3N/A
200-Day Moving Average 3N/A

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 517.08M
Float N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov 30, 2007
Most Recent Quarter (mrq)Feb 29, 2008

Profitability

Profit Margin -262.16%
Operating Margin (ttm)-169.04%

Management Effectiveness

Return on Assets (ttm)-29.94%
Return on Equity (ttm)-70.77%

Income Statement

Revenue (ttm)4.27M
Revenue Per Share (ttm)0.25
Quarterly Revenue Growth (yoy)-56.50%
Gross Profit (ttm)2.51M
EBITDA -6.74M
Net Income Avi to Common (ttm)-6.72M
Diluted EPS (ttm)-0.6580
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)403.55k
Total Cash Per Share (mrq)0.02
Total Debt (mrq)76.91k
Total Debt/Equity (mrq)1.80
Current Ratio (mrq)1.35
Book Value Per Share (mrq)0.25

Cash Flow Statement

Operating Cash Flow (ttm)-11.36M
Levered Free Cash Flow (ttm)-6.74M